BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 6285720)

  • 1. Chemotherapy of herpetic keratitis induced by acyclovir-resistant strains of herpes simplex virus type 1.
    O'Brien WJ; Taylor JL
    Am J Med; 1982 Jul; 73(1A):294-9. PubMed ID: 6285720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Herpes simplex acyclovir-resistant mutant in experimental keratouveitis.
    Boisjoly HM; Park NH; Pavan-Langston D; De Clercq E
    Arch Ophthalmol; 1983 Nov; 101(11):1782-6. PubMed ID: 6314952
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The sensitivity of acyclovir-resistant mutants of herpes simplex virus to other antiviral drugs.
    Field H; McMillan A; Darby G
    J Infect Dis; 1981 Feb; 143(2):281-5. PubMed ID: 6260876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the antiherpetic activity of acyclovir in rabbits.
    Trousdale MD; Nesburn AB
    Am J Med; 1982 Jul; 73(1A):155-60. PubMed ID: 6285707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination chemotherapy: interaction of 5-methoxymethyldeoxyuridine with trifluorothymidine, phosphonoformate and acycloguanosine against herpes simplex viruses.
    Ayisi NK; Gupta SV; Babiuk LA
    Antiviral Res; 1985 Feb; 5(1):13-27. PubMed ID: 2984988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo resistance of herpes simplex virus to 9-(2-hydroxyethoxymethyl)guanine (acycloguanosine).
    Smith KO; Kennell WL; Poirier RH; Lynd FT
    Antimicrob Agents Chemother; 1980 Feb; 17(2):144-50. PubMed ID: 6247967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acyclovir and vidarabine for the treatment of herpes simplex keratitis.
    Laibson PR; Pavan-Langston D; Yeakley WR; Lass J
    Am J Med; 1982 Jul; 73(1A):281-5. PubMed ID: 7102707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and characterization of acyclovir-resistant strains of herpes simplex virus.
    Field HJ; Larder BA; Darby G
    Am J Med; 1982 Jul; 73(1A):369-71. PubMed ID: 6285724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicenter trial of acyclovir and trifluorothymidine in herpetic keratitis.
    La Lau C; Oosterhuis JA; Versteeg J; van Rij G; Renardel de Lavalette JG; Craandijk A; Lamers WR; Mierlobensteyn T
    Am J Med; 1982 Jul; 73(1A):305-6. PubMed ID: 6808838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dendritic keratitis caused by an acyclovir-resistant herpes simplex virus with frameshift mutation.
    Zhang W; Suzuki T; Shiraishi A; Shimamura I; Inoue Y; Ohashi Y
    Cornea; 2007 Jan; 26(1):105-6. PubMed ID: 17198024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and genetic analysis of acyclovir-resistant mutants of herpes simplex virus type 1.
    Coen DM; Schaffer PA; Furman PA; Keller PM; St Clair MH
    Am J Med; 1982 Jul; 73(1A):351-60. PubMed ID: 6285722
    [No Abstract]   [Full Text] [Related]  

  • 12. Different in vitro effects of dual combinations of anti-herpes simplex virus compounds.
    Schinazi RF; Nahmias AJ
    Am J Med; 1982 Jul; 73(1A):40-8. PubMed ID: 6285731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activity of 1-(2'-fluoro-2'-deoxy-beta-D-arabinofuranosyl)thymine against herpes simplex virus in cell cultures and rabbit eyes.
    Trousdale MD; Nesburn AB; Su TL; Lopez C; Watanabe KA; Fox JJ
    Antimicrob Agents Chemother; 1983 Jun; 23(6):808-13. PubMed ID: 6311085
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of acyclovir on acute ocular infection induced by drug-resistant strains of HSV-1.
    Trousdale MD; Nesburn AB; Miller CA
    Invest Ophthalmol Vis Sci; 1981 Feb; 20(2):230-5. PubMed ID: 6257622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-resistant herpes simplex virus in vitro and after acyclovir treatment in an immunocompromised patient.
    Schnipper LE; Crumpacker CS; Marlowe SI; Kowalsky P; Hershey BJ; Levin MJ
    Am J Med; 1982 Jul; 73(1A):387-92. PubMed ID: 6285729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimetabolite drug therapy in herpes simplex.
    Kaufman HE
    Ophthalmology; 1980 Feb; 87(2):135-9. PubMed ID: 6247680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-metabolites in the management of herpes simplex keratitis.
    Kaufman HE
    Metab Pediatr Ophthalmol; 1980; 4(4):175-7. PubMed ID: 6782400
    [No Abstract]   [Full Text] [Related]  

  • 18. Virus chemotherapy: antiviral drugs and interferon.
    Kaufman HE; Varnell ED; Centifanto-Fitzgerald YM; Sanitato JG
    Antiviral Res; 1984 Dec; 4(6):333-8. PubMed ID: 6085232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Double-blind clinical trial of acyclovir and adenine arabinoside in herpetic corneal ulceration.
    Young B; Patterson A; Ravenscroft T
    Am J Med; 1982 Jul; 73(1A):311-2. PubMed ID: 7048918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapy with 9-beta-D-arabinofuranosyladenine (ARA-A) and 2'-deoxycoformycin increases the ARA-A content of ocular tissues.
    O'Brien WJ
    Curr Eye Res; 1986 Aug; 5(8):595-9. PubMed ID: 3489583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.